FDA Inspection 561249 — Los Angeles General Medical Center

Los Angeles General Medical Center — FEI 2015676

The FDA completed an inspection of Los Angeles General Medical Center on January 20, 2009 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 20, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
9321 CFR 606.100(b)(14)QC procedures for supplies and reagents